Menisoxoisoaporphine A, a novel oxoisoaporphine alkaloid from Menispermi Rhizoma, inhibits inflammation by targeting PDE4B
2024

Menisoxoisoaporphine A: A New Compound That Reduces Inflammation

publication Evidence: high

Author Information

Author(s): Qiao Xin, Cao Xiaojuan, Xu Shuang, Wang Cunlin, Guo Rui, Yao Xiaojuan, Zhang Qiong

Primary Institution: Shanxi Medical University, Taiyuan, China

Hypothesis

This study aims to investigate the anti-inflammatory effects and underlying mechanisms of Menisoxoisoaporphine A (MA).

Conclusion

Menisoxoisoaporphine A effectively inhibits inflammation in macrophage cells by targeting the PDE4B signaling pathway.

Supporting Evidence

  • MA treatment significantly reduced LPS-induced morphological changes in macrophages.
  • MA inhibited the release of inflammatory cytokines IL-6, TNF-α, and nitric oxide.
  • Transcriptome analysis indicated that PDE4B is a key target for MA's therapeutic effect.

Takeaway

A new compound called Menisoxoisoaporphine A can help reduce inflammation in cells, which is important for treating diseases like arthritis and asthma.

Methodology

The study evaluated the anti-inflammatory effects of MA in LPS-induced RAW264.7 macrophage cells using RNA sequencing and Western blotting.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fphar.2024.1505116

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication